Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Study of XMT-1660 in Participants With Solid Tumors

Study ID: NCT05377996
Start Date: 2022-08-15
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

319

Intervention / Treatment

XMT-1660

Sponsor

Mersana Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

Study ID: NCT05147558
Start Date: 2021-12-23
End Date: 2025-12-23
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Pembrolizumab

Lenvew

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Study ID: NCT06014658
Start Date: 2023-11-07
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

Antibody-Drug Conjugate

Sponsor

MBrace Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Lymphedema Surveillance Study

Study ID: NCT02743858
Start Date: 2016-04
End Date: 2025-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1250

Intervention / Treatment

Bilateral arm measurements

Body mass index (BMI)

Quality of Life Questionnaire

Blood draw

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers

Study ID: NCT06554158
Start Date: 2019-08-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Radiation Therapy

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

Study ID: NCT05121558
Start Date: 2021-10-29
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

268

Intervention / Treatment

Yoga

Education control

Usual care

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active

Study ID: NCT06649058
Start Date: 2025-02-14
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

316

Intervention / Treatment

Systemic Therapy

Stereotactic Radiosurgery

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Study ID: NCT05830058
Start Date: 2023-11-29
End Date: 2027-02-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Positron Emission Tomography

Administration questionnaire

Stereotactic Body Radiation Therapy

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Study ID: NCT05719558
Start Date: 2023-03-13
End Date: 2028-05-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

210

Intervention / Treatment

ASP1002

Sponsor

Astellas Pharma Global Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Study ID: NCT05143996
Start Date: 2021-11-18
End Date: 2025-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

Cln-049

Sponsor

Cullinan Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list